124 related articles for article (PubMed ID: 36739918)
21. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
[TBL] [Abstract][Full Text] [Related]
22. Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
Cella L; D'Avino V; Liuzzi R; Conson M; Doria F; Faiella A; Loffredo F; Salvatore M; Pacelli R
Radiat Oncol; 2013 Sep; 8():221. PubMed ID: 24053357
[TBL] [Abstract][Full Text] [Related]
23. Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients.
Meng Y; Yang H; Wang W; Tang X; Jiang C; Shen Y; Luo W
Radiat Oncol; 2019 Jan; 14(1):7. PubMed ID: 30642354
[TBL] [Abstract][Full Text] [Related]
24. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
25. Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique?
Mayinger M; Borm KJ; Dreher C; Dapper H; Duma MN; Oechsner M; Kampfer S; Combs SE; Habermehl D
Radiat Oncol; 2019 Aug; 14(1):135. PubMed ID: 31370876
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity.
Murakami Y; Murakami Y; Kamima T; Oguchi M; Abo N; Takahashi T; Kaneko M; Nakano M; Matsubayashi F; Harada A; Taguchi S; Hashimoto T; Yoshioka Y
Phys Med; 2022 Mar; 95():126-132. PubMed ID: 35158316
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Risk Model for Breast Cancer-Related Lymphedema.
Kwan JYY; Famiyeh P; Su J; Xu W; Kwan BYM; Jones JM; Chang E; Yip KW; Liu FF
JAMA Netw Open; 2020 Nov; 3(11):e2024373. PubMed ID: 33175175
[TBL] [Abstract][Full Text] [Related]
28. Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy
Kim JS; Kim JH; Chang JH; Kim DW; Shin KH
Front Oncol; 2022; 12():1026043. PubMed ID: 36387231
[TBL] [Abstract][Full Text] [Related]
29. Normal Tissue Complication Probability Modeling of Severe Radiation-Induced Lymphopenia Using Blood Dose for Patients With Hepatocellular Carcinoma.
Kim S; Byun HK; Shin J; Lee IJ; Sung W
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1011-1020. PubMed ID: 38056776
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.
Ho AY; Ballangrud A; Li G; Gupta GP; McCormick B; Gewanter R; Gelblum D; Zinovoy M; Mueller B; Mychalczak B; Dutta P; Borofsky K; Parhar P; Reyngold M; Braunstein LZ; Chawla M; Krause K; Freeman N; Siu CT; Cost Z; Arnold BB; Zhang Z; Powell SN
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1100-1108. PubMed ID: 30508620
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a risk prediction model for breast cancer-related lymphedema in postoperative patients with breast cancer.
Li MM; Wu PP; Qiang WM; Li JQ; Zhu MY; Yang XL; Wang Y
Eur J Oncol Nurs; 2023 Apr; 63():102258. PubMed ID: 36821887
[TBL] [Abstract][Full Text] [Related]
32. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
[TBL] [Abstract][Full Text] [Related]
33. Relationships among patient characteristics, irradiation treatment planning parameters, and treatment toxicity of acute radiation dermatitis after breast hybrid intensity modulation radiation therapy.
Lee TF; Sung KC; Chao PJ; Huang YJ; Lan JH; Wu HY; Chang L; Ting HM
PLoS One; 2018; 13(7):e0200192. PubMed ID: 30011291
[TBL] [Abstract][Full Text] [Related]
34. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
35. Esophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.
Dankers F; Wijsman R; Troost EG; Monshouwer R; Bussink J; Hoffmann AL
Phys Med Biol; 2017 May; 62(9):3668-3681. PubMed ID: 28379845
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of postmastectomy treatment with helical TomoTherapy.
Ashenafi M; Boyd RA; Lee TK; Lo KK; Gibbons JP; Rosen II; Fontenot JD; Hogstrom KR
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):836-42. PubMed ID: 19879697
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial.
Gross JP; Whelan TJ; Parulekar WR; Chen BE; Rademaker AW; Helenowski IB; Donnelly ED; Strauss JB
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):165-173. PubMed ID: 31085285
[TBL] [Abstract][Full Text] [Related]
38. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
[TBL] [Abstract][Full Text] [Related]
39. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
40. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
